{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:57:00Z","timestamp":1793735820324,"version":"4.6.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T00:00:00Z","timestamp":1486166400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00109-017-1511-y","type":"journal-article","created":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T09:38:45Z","timestamp":1486201125000},"page":"671-682","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["S100A8\/MYD88\/NF-\u049bB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone"],"prefix":"10.1007","volume":"95","author":[{"given":"Ana Paula Cremasco","family":"Takano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Demarchi","family":"Munhoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselmo Sigari","family":"Moriscot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhiranjan","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luiza Morais","family":"Barreto-Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,4]]},"reference":[{"key":"1511_CR1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10741-008-9125-7","volume":"15","author":"W Dillmann","year":"2010","unstructured":"Dillmann W (2010) Cardiac hypertrophy and thyroid hormone signaling. Heart Fail Rev 15:125\u2013132","journal-title":"Heart Fail Rev"},{"key":"1511_CR2","doi-asserted-by":"crossref","first-page":"20666","DOI":"10.1074\/jbc.M512671200","volume":"281","author":"A Kenessey","year":"2006","unstructured":"Kenessey A, Ojamaa K (2006) Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. J Biol Chem 281:20666\u201320672","journal-title":"J Biol Chem"},{"key":"1511_CR3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11897-008-0026-9","volume":"5","author":"P Dahl","year":"2008","unstructured":"Dahl P, Danzi S, Klein I (2008) Thyrotoxic cardiac disease. Curr Heart Fail Rep 5:170\u2013176","journal-title":"Curr Heart Fail Rep"},{"key":"1511_CR4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.freeradbiomed.2015.02.035","volume":"83","author":"MT Elnakish","year":"2015","unstructured":"Elnakish MT, Schultz EJ, Gearinger RL, Saad NS, Rastogi N, Ahmed AA, Mohler PJ, Janssen PM (2015) Differential involvement of various sources of reactive oxygen species in thyroxin-induced hemodynamic changes and contractile dysfunction of the heart and diaphragm muscles. Free Radic Biol Med 83:252\u2013261","journal-title":"Free Radic Biol Med"},{"key":"1511_CR5","doi-asserted-by":"crossref","first-page":"e46655","DOI":"10.1371\/journal.pone.0046655","volume":"7","author":"NY Weltman","year":"2012","unstructured":"Weltman NY, Wang D, Redetzke RA, Gerdes AM (2012) Longstanding hyperthyroidism is associated with normal or enhanced intrinsic cardiomyocyte function despite decline in global cardiac function. PLoS One 7:e46655","journal-title":"PLoS One"},{"key":"1511_CR6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00395-009-0043-1","volume":"104","author":"GP Diniz","year":"2009","unstructured":"Diniz GP, Carneiro-Ramos MS, Barreto-Chaves ML (2009) Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt\/GSK-3\u03b2\/mTOR signaling pathway. Basic Res Cardiol 104:653\u2013667","journal-title":"Basic Res Cardiol"},{"key":"1511_CR7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11010-010-0430-9","volume":"340","author":"A Iordanidou","year":"2010","unstructured":"Iordanidou A, Hadzopoulou-Cladaras M, Lazou A (2010) Non-genomic effects of thyroid hormone in adult cardiac myocytes: relevance to gene expression and cell growth. Mol Cell Biochem 340:291\u2013300","journal-title":"Mol Cell Biochem"},{"key":"1511_CR8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2013.05.024","volume":"376","author":"AP Takano","year":"2013","unstructured":"Takano AP, Diniz GP, Barreto-Chaves ML (2013) AMPK signaling pathway is rapidly activated by T3 and regulates the cardiomyocyte growth. Mol Cell Endocrinol 376:43\u201350","journal-title":"Mol Cell Endocrinol"},{"key":"1511_CR9","doi-asserted-by":"crossref","first-page":"e0161273","DOI":"10.1371\/journal.pone.0161273","volume":"11","author":"S Nemska","year":"2016","unstructured":"Nemska S, Monassier L, Gassmann M, Frossard N, Tavakoli R (2016) Kinetic mRNA profiling in a rat model of left-ventricular hypertrophy reveals early expression of chemokines and their receptors. PLoS One 11:e0161273","journal-title":"PLoS One"},{"key":"1511_CR10","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","volume":"116","author":"DL Mann","year":"2015","unstructured":"Mann DL (2015) Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ Res 116:1254\u20131268","journal-title":"Circ Res"},{"key":"1511_CR11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10741-016-9529-8","volume":"21","author":"E Imbalzano","year":"2016","unstructured":"Imbalzano E, Mandraffino G, Casciaro M, Quartuccio S, Saitta A, Gangemi S (2016) Pathophysiological mechanism and therapeutic role of S100 proteins in cardiac failure: a systematic review. Heart Fail Rev 21:463\u2013473","journal-title":"Heart Fail Rev"},{"key":"1511_CR12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cccn.2004.02.023","volume":"344","author":"D Foell","year":"2004","unstructured":"Foell D, Frosch M, Sorg C, Roth J (2004) Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta 344:37\u201351","journal-title":"Clin Chim Acta"},{"key":"1511_CR13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1189\/jlb.1008647","volume":"86","author":"JM Ehrchen","year":"2009","unstructured":"Ehrchen JM, Sunderk\u00f6tter C, Foell D, Vogl T, Roth J (2009) The endogenous Toll-like receptor 4 agonist S100A8\/S100A9 (calprotectin) as innate amplifier of infection, auto-immunity, and cancer. J Leukoc Biol 86:557\u2013566","journal-title":"J Leukoc Biol"},{"key":"1511_CR14","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/nm1638","volume":"13","author":"T Vogl","year":"2007","unstructured":"Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, Van Zoelen MA, Nacken W, Foell D, Van Der Poll T, Sorg C et al (2007) Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13:1042\u20131049","journal-title":"Nat Med"},{"key":"1511_CR15","doi-asserted-by":"crossref","first-page":"828354","DOI":"10.1155\/2013\/828354","volume":"2013","author":"A Schiopu","year":"2013","unstructured":"Schiopu A (2013) Cotoi OS (2013) S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease. Mediat Inflamm 2013:828354","journal-title":"Mediat Inflamm"},{"key":"1511_CR16","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/CIRCRESAHA.107.167544","volume":"102","author":"JH Boyd","year":"2008","unstructured":"Boyd JH, Kan B, Roberts H, Wang Y, Walley KR (2008) S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circ Res 102:1239\u20131246","journal-title":"Circ Res"},{"key":"1511_CR17","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1161\/HYPERTENSIONAHA.113.02843","volume":"63","author":"Y Wu","year":"2014","unstructured":"Wu Y, Li Y, Zhang C, A X, Wang Y, Cui W, Li H, Du J (2014) S100a8\/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-induced cardiac inflammation and injury. Hypertension 63:1241\u20131250","journal-title":"Hypertension"},{"key":"1511_CR18","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1073\/pnas.111155798","volume":"98","author":"NH Purcell","year":"2001","unstructured":"Purcell NH, Tang G, Yu C, Mercurio F, DiDonato JA, Lin A (2001) Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci U S A 98:6668\u20136673","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1511_CR19","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1083\/jcb.200207149","volume":"159","author":"S Gupta","year":"2002","unstructured":"Gupta S, Purcell NH, Lin A, Sen S (2002) Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy. J Cell Biol 159:1019\u20131028","journal-title":"J Cell Biol"},{"key":"1511_CR20","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.freeradbiomed.2005.08.002","volume":"39","author":"T Ha","year":"2005","unstructured":"Ha T, Li Y, Gao X, McMullen JR, Shioi T, Izumo S, Kelley JL, Zhao A, Haddad GE, Williams DL et al (2005) Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivo. Free Radic Biol Med 39:1570\u20131580","journal-title":"Free Radic Biol Med"},{"key":"1511_CR21","doi-asserted-by":"crossref","first-page":"H985","DOI":"10.1152\/ajpheart.00720.2005","volume":"290","author":"T Ha","year":"2006","unstructured":"Ha T, Hua F, Li Y, Ma J, Gao X, Kelley J, Zhao A, Haddad GE, Williams DL, Browder IW et al (2006) Blockade of MyD88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload-induced cardiac hypertrophy in vivo. Am J Physiol Heart Circ Physiol 290:H985\u2013H994","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1511_CR22","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/HJH.0b013e3283293c93","volume":"27","author":"T Li","year":"2009","unstructured":"Li T, Wang Y, Liu C, Hu Y, Wu M, Li J, Guo L, Chen L, Chen Q, Ha T et al (2009) MyD88-dependent nuclear factor-kappaB activation is involved in fibrinogen-induced hypertrophic response of cardiomyocytes. J Hypertens 27:1084\u20131093","journal-title":"J Hypertens"},{"key":"1511_CR23","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1210\/en.2015-2022","volume":"157","author":"W Gao","year":"2016","unstructured":"Gao W, Wang H, Zhang L, Cao Y, Bao JZ, Liu ZX, Wang LS, Yang Q, Lu X (2016) Retinol-binding protein 4 induces cardiomyocyte hypertrophy by activating TLR4\/MyD88 pathway. Endocrinology 157:2282\u20132293","journal-title":"Endocrinology"},{"key":"1511_CR24","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1590\/S0100-879X2000000600007","volume":"33","author":"ML Barreto-Chaves","year":"2000","unstructured":"Barreto-Chaves ML, Heimann A, Krieger JE (2000) Stimulatory effect of dexamethasone on angiotensin-converting enzyme in neonatal rat cardiac myocytes. Braz J Med Biol Res 33:661\u2013664","journal-title":"Braz J Med Biol Res"},{"key":"1511_CR25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11626-010-9368-1","volume":"47","author":"SJ Watkins","year":"2011","unstructured":"Watkins SJ, Borthwick GM, Arthur HM (2011) The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cell Dev Biol Anim 47:125\u2013131","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"1511_CR26","doi-asserted-by":"crossref","first-page":"H466","DOI":"10.1152\/ajpheart.00170.2004","volume":"289","author":"M Brown","year":"2005","unstructured":"Brown M, McGuinness M, Wright T, Ren X, Wang Y, Boivin GP, Hahn H, Feldman AM, Jones WK (2005) Cardiac-specific blockade of NF-\u049bB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo. Am J Physiol Heart Circ Physiol 289:H466\u2013H476","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1511_CR27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/ATVBAHA.111.236927","volume":"32","author":"MM Averill","year":"2012","unstructured":"Averill MM, Kerkhoff C, Bornfeldt KE (2012) S100A8 and S100A9 in cardiovascular biology and disease. Arterioscler Thromb Vasc Biol 32:223\u2013229","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1511_CR28","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/CIRCRESAHA.111.260729","volume":"110","author":"Q Liu","year":"2012","unstructured":"Liu Q, Chen Y, Auger-Messier M, Molkentin JD (2012) Interaction between NF\u03baB and NFAT coordinates cardiac hypertrophy and pathological remodeling. Circ Res 110:1077\u20131086","journal-title":"Circ Res"},{"key":"1511_CR29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.yexcr.2004.10.018","volume":"303","author":"JN Tsoporis","year":"2005","unstructured":"Tsoporis JN, Marks A, Haddad A, O\u2019Hanlon D, Jolly S, Parker TG (2005) S100A6 is a negative regulator of the induction of cardiac genes by trophic stimuli in cultured rat myocytes. Exp Cell Res 303:471\u2013481","journal-title":"Exp Cell Res"},{"key":"1511_CR30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cardiores.2007.03.027","volume":"75","author":"M Schneider","year":"2007","unstructured":"Schneider M, Kostin S, Str\u00f8m CC, Aplin M, Lyngbaek S, Theilade J, Grigorian M, Andersen CB, Lukanidin E, Lerche Hansen J et al (2007) S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes. Cardiovasc Res 75:40\u201350","journal-title":"Cardiovasc Res"},{"key":"1511_CR31","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/ATVBAHA.114.303508","volume":"34","author":"L Yan","year":"2014","unstructured":"Yan L, Mathew L, Chellan B, Gardner B, Earley J, Puri TS, Hofmann Bowman MA (2014) S100\/Calgranulin-mediated inflammation accelerates left ventricular hypertrophy and aortic valve sclerosis in chronic kidney disease in a receptor for advanced glycation end products-dependent manner. Arterioscler Thromb Vasc Biol 34:1399\u20131411","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1511_CR32","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/CIRCULATIONAHA.114.013789","volume":"131","author":"X Wei","year":"2015","unstructured":"Wei X, Wu B, Zhao J, Zeng Z, Xuan W, Cao S, Huang X, Asakura M, Xu D, Bin J et al (2015) Myocardial hypertrophic preconditioning attenuates cardiomyocyte hypertrophy and slows progression to heart failure through upregulation of S100A8\/A9. Circulation 131:1506\u20131517","journal-title":"Circulation"},{"key":"1511_CR33","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1111\/j.1742-4658.2005.04703.x","volume":"272","author":"F Rahimi","year":"2005","unstructured":"Rahimi F, Hsu K, Endoh Y, Geczy CL (2005) FGF-2, IL-1beta and TGF-beta regulate fibroblast expression of S100A8. FEBS J 272:2811\u20132827","journal-title":"FEBS J"},{"key":"1511_CR34","doi-asserted-by":"crossref","first-page":"41521","DOI":"10.1074\/jbc.M509442200","volume":"280","author":"MM McCormick","year":"2005","unstructured":"McCormick MM, Rahimi F, Bobryshev YV, Gaus K, Zreiqat H, Cai H, Lord RS, Geczy CL (2005) S100A8 and S100A9 in human arterial wall: implications for atherogenesis. J Biol Chem 280:41521\u201341529","journal-title":"J Biol Chem"},{"key":"1511_CR35","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/CIRCRESAHA.110.226928","volume":"108","author":"JW Gordon","year":"2011","unstructured":"Gordon JW, Shaw JA, Kirshenbaum LA (2011) Multiple facets of NF-\u03baB in the heart: to be or not to NF-\u03baB. Circ Res 108:1122\u20131132","journal-title":"Circ Res"},{"key":"1511_CR36","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.yjmcc.2012.01.021","volume":"52","author":"MV Singh","year":"2012","unstructured":"Singh MV, Swaminathan PD, Luczak ED, Kutschke W, Weiss RM, Anderson ME (2012) MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction. J Mol Cell Cardiol 52:1135\u20131144","journal-title":"J Mol Cell Cardiol"},{"key":"1511_CR37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.coi.2005.11.012","volume":"18","author":"LA O\u2019Neill","year":"2006","unstructured":"O\u2019Neill LA (2006) How Toll-like receptors signal: what we know and what we don\u2019t know. Curr Opin Immunol 18:3\u20139","journal-title":"Curr Opin Immunol"},{"key":"1511_CR38","doi-asserted-by":"crossref","first-page":"R501","DOI":"10.1152\/ajpregu.00194.2014","volume":"307","author":"MV Singh","year":"2014","unstructured":"Singh MV, Abboud FM (2014) Toll-like receptors and hypertension. Am J Physiol Regul Integr Comp Physiol 307:R501\u2013R504","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1511_CR39","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.bbrc.2005.10.068","volume":"338","author":"F Hua","year":"2005","unstructured":"Hua F, Ha T, Ma J, Gao X, Kelley J, Williams DL, Browder IW, Kao RL, Li C (2005) Blocking the MyD88-dependent pathway protects the myocardium from ischemia\/reperfusion injury in rat hearts. Biochem Biophys Res Commun 338:1118\u20131125","journal-title":"Biochem Biophys Res Commun"},{"key":"1511_CR40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1073\/pnas.1318115111","volume":"111","author":"V Alverdi","year":"2014","unstructured":"Alverdi V, Hetrick B, Joseph S, Komives EA (2014) Direct observation of a transient ternary complex during I\u03baB\u03b1-mediated dissociation of NF-\u03baB from DNA. Proc Natl Acad Sci U S A 111:225\u2013230","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1511_CR41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1385\/CT:3:3:229","volume":"3","author":"WK Jones","year":"2003","unstructured":"Jones WK, Brown M, Ren X, He S, McGuinness M (2003) NF-kappaB as an integrator of diverse signaling pathways: the heart of myocardial signaling? Cardiovasc Toxicol 3:229\u2013254","journal-title":"Cardiovasc Toxicol"},{"key":"1511_CR42","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1074\/jbc.M115.711697","volume":"291","author":"C Reale","year":"2016","unstructured":"Reale C, Iervolino A, Scudiero I, Ferravante A, D'Andrea LE, Mazzone P, Zotti T, Leonardi A, Roberto L, Zannini M et al (2016) NF-\u03baB essential modulator (NEMO) is critical for thyroid function. J Biol Chem 291:5765\u20135773","journal-title":"J Biol Chem"},{"key":"1511_CR43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.febslet.2004.06.056","volume":"571","author":"HM Shin","year":"2004","unstructured":"Shin HM, Kim MH, Kim BH, Jung SH, Kim YS, Park HJ, Hong JT, Min KR, Kim Y (2004) Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-kappaB without affecting IkappaB degradation. FEBS Lett 571:50\u201354","journal-title":"FEBS Lett"},{"key":"1511_CR44","doi-asserted-by":"crossref","first-page":"R1473","DOI":"10.1152\/ajpregu.00269.2003","volume":"285","author":"LW Hu","year":"2003","unstructured":"Hu LW, Benvenuti LA, Liberti EA, Carneiro-Ramos MS, Barreto-Chaves ML (2003) Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling. Am J Physiol Regul Integr Comp Physiol 285:R1473\u2013R1480","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1511_CR45","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yjmcc.2014.01.013","volume":"70","author":"K Fujiu","year":"2014","unstructured":"Fujiu K, Nagai R (2014) Fibroblast-mediated pathways in cardiac hypertrophy. J Mol Cell Cardiol 70:64\u201373","journal-title":"J Mol Cell Cardiol"},{"key":"1511_CR46","doi-asserted-by":"crossref","first-page":"H20","DOI":"10.1152\/ajpheart.00082.2005","volume":"289","author":"S Gupta","year":"2005","unstructured":"Gupta S, Young D, Sen S (2005) Inhibition of NF-kappaB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 289:H20\u2013H29","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1511_CR47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/CIRCHEARTFAILURE.114.001297","volume":"8","author":"H Javan","year":"2015","unstructured":"Javan H, Szucsik AM, Li L, Schaaf CL, Salama ME, Selzman CH (2015) Cardiomyocyte p65 nuclear factor-\u03baB is necessary for compensatory adaptation to pressure overload. Circ Heart Fail 8:109\u2013118","journal-title":"Circ Heart Fail"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-017-1511-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-017-1511-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-017-1511-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T07:56:17Z","timestamp":1495526177000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-017-1511-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,4]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["1511"],"URL":"https:\/\/doi.org\/10.1007\/s00109-017-1511-y","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,4]]}}}